FFA
IART icon

Farther Finance Advisors’s Integra LifeSciences IART Stock Holding History

Farther Finance Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.1K Sell
1,848
-66
-3% -$1.14K ﹤0.01% 3829
2026
Q2 		$34.6K Buy
1,914
+1,199
+168% +$16.8K ﹤0.01% 3548
2026
Q1 		$6.84K Sell
715
-100
-12% -$1.1K ﹤0.01% 4331
2025
Q4 		$10.1K Buy
815
+294
+56% +$3.91K ﹤0.01% 3900
2025
Q3 		$7.47K Buy
521
+121
+30% +$1.66K ﹤0.01% 3575
2025
Q2 		$4.91K Sell
400
-40
-9% -$581 ﹤0.01% 3364
2025
Q1 		$9.51K Buy
440
+400
+1,000% +$9.41K ﹤0.01% 2761
2024
Q4 		$907 Sell
40
-15
-27% -$327 ﹤0.01% 3283
2024
Q3 		$999 Sell
55
-7,509
-99% -$174K ﹤0.01% 3245
2024
Q2 		$219K Buy
7,564
+7,499
+11,537% +$222K 0.01% 806
2024
Q1 		$2.26K Sell
65
-49
-43% -$1.96K ﹤0.01% 2436
2023
Q4 		$4.96K Buy
+114
New +$4.49K ﹤0.01% 1969
2023
Q3 		– Sell
-5
Closed -$206 – 2650
2023
Q2 		$206 Sell
5
-12
-71% -$578 ﹤0.01% 2364
2023
Q1 		$976 Buy
17
+12
+240% +$676 ﹤0.01% 1852
2022
Q4 		$280 Buy
+5
New +$254 ﹤0.01% 1958

Other funds holding IART

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Farther Finance Advisors's IART Position: Q3 2026 in Review

Farther Finance Advisors reduced its Integra LifeSciences (IART) stake by 3.4% in Q3 2026, selling an estimated $1.14K and leaving 1,848 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3829.

Farther Finance Advisors first reported a position in IART in Q4 2022 and has held it in 15 quarters since. The position peaked at $219K in Q2 2024. 5 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Farther Finance Advisors held 1,848 shares of Integra LifeSciences worth $30.1K as of Q3 2026.
  • Farther Finance Advisors sold 66 Integra LifeSciences shares in Q3 2026, an estimated $1.14K.
  • Integra LifeSciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3829 holding.
  • Farther Finance Advisors first reported a position in Integra LifeSciences in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Integra LifeSciences position peaked at $219K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.